Dashboard
Manage Tickers

ZLABZai Lab Ltd

Nasdaq zailaboratory.com


$ 19.05 $ 0.68 (3.7 %)    

Wednesday, 31-Jul-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.32 $ 8.28 (1.78 %)
DIA $ 408.46 $ 1.05 (0.26 %)
SPY $ 551.56 $ 3.52 (0.64 %)
TLT $ 94.83 $ 0.98 (1.04 %)
GLD $ 226.56 $ 4.04 (1.82 %)
$ 18.37
$ 19.17
$ 18.93 x 100
-- x --
$ 18.82 - $ 19.48
$ 13.48 - $ 31.66
568,336
na
17.88B
$ 1.03
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Zai Lab And argenx Get Approval For Efgart...
07/16/2024 05:13:51

First and only NMPA-approved subcutaneous (SC) injectable providing additional flexibility and optionality for gMG patients i...

zai-lab-announces-publication-from-chinas-gynecology-oncology-field-in-cell-study-highlights-niraparibs-effect-on-ovarian-cancer-microenvironment-stratified-by-hrd-and-its-perturbation-by-parp-inhibitor-data-suggest-combination-of-niraparib-and-investigational-ccr8-antibody-zl-1218-may-decrease-tumor-burden
Zai Lab Announces Publication From China's...
07/15/2024 18:57:11

Manuscript represents the first publication from China's gynecology oncology field to be published in CellPublication highl...

jp-morgan-maintains-overweight-on-zai-lab-lowers-price-target-to-38
JP Morgan Maintains Overweight on Zai Lab,...
07/12/2024 15:09:59

JP Morgan analyst Anupam Rama maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $43 to $38.

cantor-fitzgerald-reiterates-overweight-on-zai-lab
Cantor Fitzgerald Reiterates Overweight on...
07/01/2024 13:12:48

Cantor Fitzgerald analyst Louise Chen reiterates Zai Lab (NASDAQ:ZLAB) with a Overweight.

cantor-fitzgerald-reiterates-overweight-on-zai-lab
Cantor Fitzgerald Reiterates Overweight on...
06/25/2024 14:58:08

Cantor Fitzgerald analyst Louise Chen reiterates Zai Lab (NASDAQ:ZLAB) with a Overweight.

why-core--main-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Core & Main Shares Are Trading Lower B...
06/04/2024 16:54:09

saia-annexon-core-scientific-and-other-big-stocks-moving-higher-on-tuesday
Saia, Annexon, Core Scientific And Other B...
06/04/2024 14:08:59

zai-lab-has-dosed-the-first-patient-in-the-phase-2-trial-of-zl-1102-for-chronic-plaque-psoriasis
Zai Lab Has Dosed The First Patient In The...
05/22/2024 11:34:45

This is the first compound in Zai's portfolio of internally developed drugs to advance into Phase 2, demonstrating Zai...

Core News & Articles
Zai Lab And Innoviva Specialty Therapeutic...
05/20/2024 04:40:14

Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, ...

reported-sunday-zai-lab-received-approval--of-augtyro-repotrectinib-for-patients-with-ros1-positive-nsclc-by-chinas-national-medical-products-administration
Reported Sunday, Zai Lab Received Approval...
05/13/2024 06:30:58

The approval is based on the pivotal TRIDENT-1 trial, in which AUGTYRO achieved a high response rate and durable responses, inc...

why-duolingo-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Duolingo Shares Are Trading Lower By A...
05/09/2024 17:57:05

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 16:31:09

spectrum-brands-posts-upbeat-results-joins-aersale-sinclair-icu-medical-and-other-big-stocks-moving-higher-on-thursday
Spectrum Brands Posts Upbeat Results, Join...
05/09/2024 14:25:23

top-5-health-care-stocks-that-could-sink-your-portfolio-in-q2
Top 5 Health Care Stocks That Could Sink Y...
05/09/2024 12:44:39

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

zai-lab-q1-2024-gaap-eps-055-beats-094-estimate-sales-8710m-beat-7524m-estimate
Zai Lab Q1 2024 GAAP EPS $(0.55) Beats $(0...
05/08/2024 20:19:36

Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.94) by 41...

one-good-one-bad-news-for-bristol-myers-squibbs-marketed-drugs-details
One Good, One Bad News For Bristol Myers S...
04/01/2024 13:44:31

Bristol Myers Squibb shares update on Phase 3 YELLOWSTONE trial for Zeposia (ozanimod) in Crohn's disease. Primary endpoint...

Core News & Articles
Zai Lab Shares Higher; Co Noted Partner B...
04/01/2024 11:34:31

Core News & Articles
Novocure Announces METIS Phase 3 Clinical ...
03/27/2024 13:30:21

The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Field...

stock-disconnect-triggers-investor-exodus-from-cstone-pharma
Stock Disconnect Triggers Investor Exodus ...
03/14/2024 18:48:29

Key Takeaways: CEO Jason Yang has increased his CStone stake multiple times over the past 18 months to 4.79% of outstanding ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)